guest ::
| Home > Publications Database > Activation of polo-like kinase 1 correlates with selective motor neuron vulnerability in familial ALS. > print |
| Home > Publications Database > Activation of polo-like kinase 1 correlates with selective motor neuron vulnerability in familial ALS. > print |
| 001 | 280968 | ||
| 005 | 20250921002015.0 | ||
| 024 | 7 | _ | |a 10.1016/j.celrep.2025.116113 |2 doi |
| 024 | 7 | _ | |a pmid:40857153 |2 pmid |
| 024 | 7 | _ | |a 2211-1247 |2 ISSN |
| 024 | 7 | _ | |a 2639-1856 |2 ISSN |
| 024 | 7 | _ | |a altmetric:180623124 |2 altmetric |
| 037 | _ | _ | |a DZNE-2025-01050 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Szewczyk, Barbara |0 P:(DE-2719)9000982 |b 0 |u dzne |
| 245 | _ | _ | |a Activation of polo-like kinase 1 correlates with selective motor neuron vulnerability in familial ALS. |
| 260 | _ | _ | |a Maryland Heights, MO |c 2025 |b Cell Press |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1756890480_1282 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 520 | _ | _ | |a Mutations in the Fused in Sarcoma (FUS) gene cause familial amyotrophic lateral sclerosis (ALS), characterized by selective degeneration of spinal motor neurons (sMNs) with relative sparing of cortical neurons (CNs). The mechanisms underlying this cell-type vulnerability remain unclear. Here, we compare CNs and sMNs derived from FUS-ALS models to assess differential responses to FUS mutations. We find that CNs are less affected than sMNs in DNA damage repair, axonal organelle trafficking, and stress granule dynamics. RNA sequencing (RNA-seq) reveals distinct transcriptomic signatures, with sMNs uniquely activating DNA damage responses involving cell cycle regulators, particularly polo-like kinase 1 (PLK1). PLK1 is highly expressed in sMNs but not CNs, correlating with greater nuclear FUS loss and splicing defects in sMNs. Cross-comparison with other familial ALS RNA-seq datasets highlights PLK1 upregulation as a shared molecular feature. These findings identify intrinsic differences between CNs and sMNs in FUS-ALS and suggest PLK1 as a potential driver of sMN vulnerability. |
| 536 | _ | _ | |a 353 - Clinical and Health Care Research (POF4-353) |0 G:(DE-HGF)POF4-353 |c POF4-353 |f POF IV |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de |
| 650 | _ | 7 | |a CP: Molecular biology |2 Other |
| 650 | _ | 7 | |a CP: Neuroscience |2 Other |
| 650 | _ | 7 | |a DNA damage response |2 Other |
| 650 | _ | 7 | |a FUS loss of function |2 Other |
| 650 | _ | 7 | |a FUS-ALS |2 Other |
| 650 | _ | 7 | |a PLK1 |2 Other |
| 650 | _ | 7 | |a neurodegeneration |2 Other |
| 650 | _ | 7 | |a polo-like kinase 1 |2 Other |
| 650 | _ | 7 | |a selective vulnerability |2 Other |
| 650 | _ | 7 | |a transcriptomics |2 Other |
| 700 | 1 | _ | |a Zimyanin, Vitaly |b 1 |
| 700 | 1 | _ | |a Japtok, Julia |b 2 |
| 700 | 1 | _ | |a Held, Aaron |b 3 |
| 700 | 1 | _ | |a Pal, Arun |b 4 |
| 700 | 1 | _ | |a Großmann, Dajana |b 5 |
| 700 | 1 | _ | |a Glaß, Hannes |b 6 |
| 700 | 1 | _ | |a Jürs, Alexandra V |b 7 |
| 700 | 1 | _ | |a Dash, Banaja P |b 8 |
| 700 | 1 | _ | |a Bak, Maciek |b 9 |
| 700 | 1 | _ | |a Naumann, Marcel |b 10 |
| 700 | 1 | _ | |a Hartmann, Christiane |b 11 |
| 700 | 1 | _ | |a Kuksenko, Olena |b 12 |
| 700 | 1 | _ | |a Günther, René |0 P:(DE-2719)2811849 |b 13 |u dzne |
| 700 | 1 | _ | |a Kao, Tzu-Ting |b 14 |
| 700 | 1 | _ | |a Sameith, Katrin |b 15 |
| 700 | 1 | _ | |a Dahl, Andreas |b 16 |
| 700 | 1 | _ | |a Sterneckert, Jared |b 17 |
| 700 | 1 | _ | |a Aronica, Eleonora |b 18 |
| 700 | 1 | _ | |a Shneider, Neil A |b 19 |
| 700 | 1 | _ | |a Büttner, Andreas |b 20 |
| 700 | 1 | _ | |a Catanese, Alberto |0 P:(DE-2719)9001873 |b 21 |u dzne |
| 700 | 1 | _ | |a Phatnani, Hemali |b 22 |
| 700 | 1 | _ | |a Kipp, Markus |0 P:(DE-HGF)0 |b 23 |
| 700 | 1 | _ | |a Wainger, Brian J |b 24 |
| 700 | 1 | _ | |a Goswami, Anand |b 25 |
| 700 | 1 | _ | |a Hermann, Andreas |0 P:(DE-2719)2811732 |b 26 |e Last author |u dzne |
| 773 | _ | _ | |a 10.1016/j.celrep.2025.116113 |g Vol. 44, no. 9, p. 116113 - |0 PERI:(DE-600)2649101-1 |n 9 |p 116113 |t Cell reports |v 44 |y 2025 |x 2211-1247 |
| 856 | 4 | _ | |y OpenAccess |u https://pub.dzne.de/record/280968/files/DZNE-2025-01050.pdf |
| 856 | 4 | _ | |u https://pub.dzne.de/record/280968/files/DZNE-2025-01050%20SUP.zip |
| 856 | 4 | _ | |u https://pub.dzne.de/record/280968/files/DZNE-2025-01050.pdf?subformat=pdfa |x pdfa |y OpenAccess |
| 909 | C | O | |o oai:pub.dzne.de:280968 |p openaire |p open_access |p VDB |p driver |p dnbdelivery |
| 910 | 1 | _ | |a External Institute |0 I:(DE-HGF)0 |k Extern |b 0 |6 P:(DE-2719)9000982 |
| 910 | 1 | _ | |a External Institute |0 I:(DE-HGF)0 |k Extern |b 13 |6 P:(DE-2719)2811849 |
| 910 | 1 | _ | |a External Institute |0 I:(DE-HGF)0 |k Extern |b 21 |6 P:(DE-2719)9001873 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 23 |6 P:(DE-HGF)0 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 26 |6 P:(DE-2719)2811732 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Neurodegenerative Diseases |1 G:(DE-HGF)POF4-350 |0 G:(DE-HGF)POF4-353 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Clinical and Health Care Research |x 0 |
| 914 | 1 | _ | |y 2025 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2024-12-16 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2024-12-16 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2024-12-16 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2024-12-16 |
| 915 | _ | _ | |a Creative Commons Attribution CC BY 4.0 |0 LIC:(DE-HGF)CCBY4 |2 HGFVOC |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b CELL REP : 2022 |d 2024-12-16 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0501 |2 StatID |b DOAJ Seal |d 2023-05-02T08:49:39Z |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0500 |2 StatID |b DOAJ |d 2023-05-02T08:49:39Z |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2024-12-16 |
| 915 | _ | _ | |a Fees |0 StatID:(DE-HGF)0700 |2 StatID |d 2024-12-16 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2024-12-16 |
| 915 | _ | _ | |a OpenAccess |0 StatID:(DE-HGF)0510 |2 StatID |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b DOAJ : Anonymous peer review |d 2023-05-02T08:49:39Z |
| 915 | _ | _ | |a Article Processing Charges |0 StatID:(DE-HGF)0561 |2 StatID |d 2024-12-16 |
| 915 | _ | _ | |a IF >= 5 |0 StatID:(DE-HGF)9905 |2 StatID |b CELL REP : 2022 |d 2024-12-16 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2024-12-16 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2024-12-16 |
| 920 | 1 | _ | |0 I:(DE-2719)1511100 |k AG Hermann |l Translational Neurodegeneration |x 0 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a UNRESTRICTED |
| 980 | _ | _ | |a I:(DE-2719)1511100 |
| 980 | 1 | _ | |a FullTexts |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|